Abstract:Background: Circulating tumor cells (CTCs) have long been considered a reflection of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a crucial step in the metastasis cascade, which leads ultimately to the formation of overt metastases. However, owing to the rarity of CTCs in peripheral blood, detecting these cells requires methods combined with high sensitivity and specificity, which sets tremendous challenges for the implementation of these assays into clinical routine. Methods: Generally, CTCs detection methods are composed of the following two steps: enrichment (isolation) process (morphological and immunological techniques) and detection (identification) process (cytometric and nucleic acid techniques), which may or may not be separate from enrichment. Genetic and molecular characterization of CTCs carried out by fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), PCR-based techniques, and biomarker immunofluorescent staining extract more information about malignant profile, metastatic potential of CTCs, and the extent to which CTCs are genetically identical to the primary tumor. Results: Recent technical advances made it possible to detect CTCs. The efficacy of circulating tumor cell (CTC) detection among patients with solid malignancy has been investigated, which shows great potential to become a tool for real-time parameter of prognosis and serve as an early marker to assess the therapeutic response in overt cancers. Improvements in detection and characterization of CTCs will hopefully lead to refinement of clinical management of cancer patients. Conclusion: This review addresses the majority of assays that have been published thus far, including the enrichment and detection steps and the markers used in these assays, accompanied by some biological issues of CTC and the results of clinical application harvested.

Research Progress of CDT.

[Current Status and Latest Advancement in Developing Techniques for Tumor Early Detection].

Research Progress on Circulating Tumor Cells and Their Detection in Colorectal Cancer

Advances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques

Advances in early detection methods for solid tumors

Application of Circulating Tumor DNA in Precision Diagnosis and Treatment of Colorectal Cancer

Clinical Progress of the Research an Circulating Tumor Cells in Colorectal Cancer

"Liquid biopsy"-ctDNA detection with great potential and challenges.

Detection of circulating tumor cells: opportunities and challenges

Circulating tumor DNA analysis for tumor diagnosis

Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control

Development of liquid biopsy in detection and screening of pancreatic cancer

Liquid biopsy in cancer current: status, challenges and future prospects

Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Current research status of tumor cell biomarker detection

Blood-based multi-cancer detection: A state-of-the-art update

Bibliometric analysis of global research trends and prospects on circulating tumor DNA in colorectal cancer

The advanced development of molecular targeted therapy for hepatocellular carcinoma

Circulating tumor DNA: from discovery to clinical application in breast cancer